 | Articles: Drug Approvals |
GleevecTM for the Treatment of Chronic Myelogenous Leukemia: U.S. Food and Drug Administration Regulatory Mechanisms, Accelerated Approval, and Orphan Drug Status
The Oncologist, 10/28/02
Drug expands options for addiction care
American Medical News , 10/28/02
FDA approves Pegasys for hepatitis C
Pharmaceutical Executive, 10/18/02
 | | Sponsor |
Invitation to Meet With U.S. and EU Clinical Investigators in Maxim Phase 3 Melanoma Clinical Trials and Update of Three-Year Phase 3 Follow-Up Data
Maxim Pharmaceuticals, 10/15/02
FDA approves GlaxoSmithKlines Avandamet¿ for the treatment of type 2 diabetes
GlaxoSmithKline, 10/14/02
FDA approves Avodart, the first dual-acting 5 alpha-reductase inhibitor for benign prostatic hyperplasia (BPH)
GlaxoSmithKline, 10/11/02
New Headache Relief - No Water Needed
Bristol Myers-Squibb Company, 10/08/02
Allergan Receives Approval From the FDA for AVAGE to Treat Fine Facial Wrinkles
Allergan, 10/02/02
FDA Approves INSPRA¿, An Aldosterone Blocker for the Treatment of Hypertension
Pharmacia, 10/01/02
New Dietary Recommendations For Infants
Bristol Myers-Squibb Company, 09/26/02
|
 Receive daily email updates on Drug Approvals
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
119 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
|
